- Home
- IPHA vs FONR Comparison
IPHA vs FONR Comparison
Compare IPHA & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | FONR |
|---|---|---|
| Founded | 1999 | 1978 |
| Country | France | United States |
| Employees | 174 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.1M | 117.8M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | IPHA | FONR |
|---|---|---|
| Price | $1.37 | $18.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | 13.7K | ★ 52.2K |
| Earning Date | 03-26-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $104,351,318.00 |
| Revenue This Year | $28.31 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.86 |
| Revenue Growth | N/A | ★ 1.43 |
| 52 Week Low | $1.18 | $12.00 |
| 52 Week High | $2.63 | $18.86 |
Technical Indicators
Market Signals| Indicator | IPHA | FONR |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 57.82 |
| Support Level | N/A | $18.49 |
| Resistance Level | $1.88 | $18.69 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 24.96 | 74.19 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.